The high detection rate of PTCH1 mutations among NBCCS patients, as demonstrated in the present study as well as other previous ones [34], [39], poses the possibility to include genetic analysis of PTCH1 in the new diagnostic criteria for early diagnosis. Here, PTCH1 is linked to nevoid basal cell carcinoma syndrome.